chr10-53831553-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001384140.1(PCDH15):c.3984-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 1,521,810 control chromosomes in the GnomAD database, including 134,757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11786 hom., cov: 33)
Exomes 𝑓: 0.42 ( 122971 hom. )
Consequence
PCDH15
NM_001384140.1 intron
NM_001384140.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0570
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-53831553-G-A is Benign according to our data. Variant chr10-53831553-G-A is described in ClinVar as [Benign]. Clinvar id is 46476.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53831553-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.729 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.3984-20C>T | intron_variant | Intron 29 of 32 | 1 | NM_033056.4 | ENSP00000322604.6 | |||
PCDH15 | ENST00000644397.2 | c.3984-20C>T | intron_variant | Intron 29 of 37 | NM_001384140.1 | ENSP00000495195.1 |
Frequencies
GnomAD3 genomes AF: 0.383 AC: 58115AN: 151836Hom.: 11788 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
58115
AN:
151836
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.430 AC: 105821AN: 246134 AF XY: 0.427 show subpopulations
GnomAD2 exomes
AF:
AC:
105821
AN:
246134
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.417 AC: 570689AN: 1369856Hom.: 122971 Cov.: 21 AF XY: 0.417 AC XY: 286528AN XY: 686630 show subpopulations
GnomAD4 exome
AF:
AC:
570689
AN:
1369856
Hom.:
Cov.:
21
AF XY:
AC XY:
286528
AN XY:
686630
Gnomad4 AFR exome
AF:
AC:
9270
AN:
31472
Gnomad4 AMR exome
AF:
AC:
20647
AN:
44190
Gnomad4 ASJ exome
AF:
AC:
8571
AN:
25502
Gnomad4 EAS exome
AF:
AC:
30878
AN:
39096
Gnomad4 SAS exome
AF:
AC:
39475
AN:
83822
Gnomad4 FIN exome
AF:
AC:
20508
AN:
53154
Gnomad4 NFE exome
AF:
AC:
416392
AN:
1029882
Gnomad4 Remaining exome
AF:
AC:
23265
AN:
57266
Heterozygous variant carriers
0
14904
29808
44712
59616
74520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
12770
25540
38310
51080
63850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.383 AC: 58131AN: 151954Hom.: 11786 Cov.: 33 AF XY: 0.384 AC XY: 28486AN XY: 74272 show subpopulations
GnomAD4 genome
AF:
AC:
58131
AN:
151954
Hom.:
Cov.:
33
AF XY:
AC XY:
28486
AN XY:
74272
Gnomad4 AFR
AF:
AC:
0.300603
AN:
0.300603
Gnomad4 AMR
AF:
AC:
0.406684
AN:
0.406684
Gnomad4 ASJ
AF:
AC:
0.346443
AN:
0.346443
Gnomad4 EAS
AF:
AC:
0.748259
AN:
0.748259
Gnomad4 SAS
AF:
AC:
0.480897
AN:
0.480897
Gnomad4 FIN
AF:
AC:
0.372984
AN:
0.372984
Gnomad4 NFE
AF:
AC:
0.396686
AN:
0.396686
Gnomad4 OTH
AF:
AC:
0.377367
AN:
0.377367
Heterozygous variant carriers
0
1798
3597
5395
7194
8992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1966
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 29, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Usher syndrome type 1F Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at